Given data suggesting that interactions among T lymphocyte subsets may regulate the host-mediated anti-tumor reaction [9], [10], we examined the association of FoxP3+ and CD8+ T cells with patient prognosis in stage II and III colon cancers from participants in adjuvant chemotherapy studies. The gene discussed is FOXP3; the disease is malignant colon neoplasm.